HROW Q4 2022 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena

HROWHarrow Health, Inc.

$1B

Q4 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$20M+0.7% YoY

Gross Profit

$14M69.7% margin

Operating Income

-$2M-8.7% margin

Net Income

$1M5.2% margin

EPS (Diluted)

$0.04

QoQ Revenue Growth

-10.9%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$5M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$157M

Total Liabilities

$130M

Stockholders' Equity

$28M

Cash & Equivalents

$96M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$20M	$20M	+0.7%
Gross Profit	$14M	$15M	-6.2%
Operating Income	-$2M	-$2M	-1.3%
Net Income	$1M	-$7M	+114.2%

Revenue Segments

Other Revenues

$238,000100%